BOSTON (Reuters) - Injections of an enzyme that breaks up collagen can unlock permanently curled fingers for people with a common disabling condition known as Dupuytren's contracture, U.S. researchers ...
Novartis obtained portfolio-level options for exclusive rights to Hybrozyme-enabled SC formulations, with economics up to ...
YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a South Korean biopharmaceutical company, and Clinigen K.K. (“Clinigen”), headquartered in ...
Alteogen has exported technology to global pharmaceutical company Novartis to convert intravenous injections into simpler ...